The Next Stage of Buprenorphine Care for Opioid Use Disorder
Authors: Stephen A. Martin, Lisa M. Chiodo, Jordon D. Bosse, Amanda Wilson
Journal: Annals of Internal Medicine (2019)

Letters4 June 2019The Next Stage of Buprenorphine Care for Opioid Use DisorderStephen A. Martin, MD, EdM, Lisa M. Chiodo, PhD, Jordon D. Bosse, MS, RN, and Amanda Wilson, MDStephen A. Martin, MD, EdMUniversity of Massachusetts Medical School and Barre Family Health Center and CleanSlate Research and Education Foundation, Barre and Florence, Massachusetts (S.A.M.), Lisa M. Chiodo, PhDUniversity of Massachusetts Amherst College of Nursing and CleanSlate Research and Education Foundation, Amherst and Florence, Massachusetts (L.M.C., J.D.B.), Jordon D. Bosse, MS, RNUniversity of Massachusetts Amherst College of Nursing and CleanSlate Research and Education Foundation, Amherst and Florence, Massachusetts (L.M.C., J.D.B.), and Amanda Wilson, MDCleanSlate Research and Education Foundation, Florence, Massachusetts (A.W.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L19-0145 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:We appreciate Dr. Malinoff's concern about a potential conflict of interest. CleanSlate Addiction Treatment Centers played no part in the conception or writing of our article. The CleanSlate Research and Education Foundation, a 501(c)(3) organization that participates in research funded by the National Institutes of Health and is part of the National Institute on Drug Abuse Clinical Trials Network, is entirely separate from—and is uninfluenced by—CleanSlate Addiction Treatment Centers. Given the intentional separation between the 2 organizations, it would not be appropriate for the CleanSlate Research and Education Foundation to comment on concerns regarding CleanSlate Addiction Treatment Centers.... References1. Hawk K, D'Onofrio G. Time to change the way we approach opioid use disorder: a challenge to the status quo. Ann Intern Med. 2018;169:652-3. [PMID: 30357257]. doi:10.7326/M18-2722 LinkGoogle Scholar2. Friedmann PD, Suzuki J. More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic. Addict Sci Clin Pract. 2017;12:29. [PMID: 29141667] doi:10.1186/s13722-017-0092-y CrossrefMedlineGoogle Scholar3. Mojtabai R, Mauro C, Wall MM, Barry CL, Olfson M. Medication treatment for opioid use disorders in substance use treatment facilities. Health Aff (Millwood). 2019;38:14-23. [PMID: 30615514] doi:10.1377/hlthaff.2018.05162 CrossrefMedlineGoogle Scholar4. Simpkin AL, Schwartzstein RM. Tolerating uncertainty—the next medical revolution? N Engl J Med. 2016;375:1713-5. [PMID: 27806221] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: University of Massachusetts Medical School and Barre Family Health Center and CleanSlate Research and Education Foundation, Barre and Florence, Massachusetts (S.A.M.)University of Massachusetts Amherst College of Nursing and CleanSlate Research and Education Foundation, Amherst and Florence, Massachusetts (L.M.C., J.D.B.)CleanSlate Research and Education Foundation, Florence, Massachusetts (A.W.)Note: Drs. Martin and Chiodo and Mr. Bosse are also affiliated with CleanSlate Research and Education Foundation.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-1652. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Next Stage of Buprenorphine Care for Opioid Use Disorder Stephen A. Martin , Lisa M. Chiodo , Jordon D. Bosse , and Amanda Wilson The Next Stage of Buprenorphine Care for Opioid Use Disorder Robert Sherrick The Next Stage of Buprenorphine Care for Opioid Use Disorder Barbara Scolnick The Next Stage of Buprenorphine Care for Opioid Use Disorder Mark H. Duncan , Anna D. Ratzliff , Diane M. Powers , Caleb J. Banta-Green , and Andrew J. Saxon The Next Stage of Buprenorphine Care for Opioid Use Disorder Herbert Malinoff Metrics Cited byComparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance UseOpioid use disorder from poppy seed tea successfully treated with buprenorphine in primary care: a case reportBuprenorphine-Related Deaths in North Carolina from 2010 to 2018Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use DrugsManagement of Opioid Use Disorder in the Emergency Department: A White Paper Prepared for the American Academy of Emergency Medicine 4 June 2019Volume 170, Issue 11Page: 821-822KeywordsConflicts of interestDisclosureInpatientsNeuropathic painOpioid addictionOpioidsPatientsPrevention, policy, and public healthToxicology ePublished: 4 June 2019 Issue Published: 4 June 2019 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...